Table 6.
MSCT and MRI findings in T and N restaging of rectal cancer after NCRT [n (%)].
| Methods of examination | T restaging (n = 62) | N restaging (n = 62) | ||||
|---|---|---|---|---|---|---|
| Overstaging | Accurate staging | Low staging | Overstaging | Accurate staging | Low staging | |
| MSCT | 24 (38.7) | 32 (51.6) | 6 (9.7) | 18 (29.0) | 35 (56.5) | 9 (14.5) |
| MRI | 29 (46.8) | 26 (41.9) | 7 (11.3) | 22 (35.5) | 33 (53.2) | 7 (11.3) |
| χ² | 1.169 | 0.709 | ||||
| P | 0.557 | 0.702 | ||||
MSCT, multi-slice computed tomography; MRI, magnetic resonance imaging; T, tumor; N, node; NCRT, neoadjuvant chemoradiotherapy.